Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simrit Parmar

Showing results (61-70 of 119) with videos related to

Pageof 12
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 18, 2018
Impact of Induction Therapy on the Outcome of Immunoglobulin Light Chain Amyloidosis after Autologous Hematopoietic Stem Cell TransplantationAimaz Afrough, Rima M Saliba, Amir Hamdi, et al.
Leukemia & Lymphoma|July 26, 2011
Feasibility of autologous hematopoietic stem cell transplant in patients aged ≥70 years with multiple myelomaQaiser Bashir, Nina Shah, Simrit Parmar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 25, 2015
General and Virus-Specific Immune Cell Reconstitution after Double Cord Blood TransplantationRima M Saliba, Katayoun Rezvani, Ann Leen, et al.
Bone Marrow Transplantation|November 18, 2018
Primary plasma cell leukemia: autologous stem cell transplant in an era of novel induction drugsLohith Gowda, Mithun Shah, Ifra Badar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 6, 2015
Outcome of Patients with Immunoglobulin Light-Chain Amyloidosis with Lung, Liver, Gastrointestinal, Neurologic, and Soft Tissue Involvement after Autologous Hematopoietic Stem Cell TransplantationAimaz Afrough, Rima M Saliba, Amir Hamdi, et al.
American Journal of Hematology|July 16, 2016
Outcomes in patients with multiple myeloma with TP53 deletion after autologous hematopoietic stem cell transplantSameh Gaballa, Rima M Saliba, Samer Srour, et al.
Blood|August 6, 2009
Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host diseaseSimrit Parmar, Marcos Del Lima, Yizhou Zou, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 17, 2017
Ex Vivo Mesenchymal Precursor Cell-Expanded Cord Blood Transplantation after Reduced-Intensity Conditioning Regimens Improves Time to Neutrophil RecoveryRohtesh S Mehta, Rima M Saliba, Kai Cao, et al.
The Lancet. Haematology|May 20, 2017
High-dose gemcitabine, busulfan, and melphalan for autologous stem-cell transplant in patients with relapsed or refractory myeloma: a phase 2 trial and matched-pair comparison with melphalanYago Nieto, Benigno C Valdez, Sai R Pingali, et al.
British Journal of Haematology|March 16, 2017
Long-term follow-up of patients receiving allogeneic stem cell transplant for chronic lymphocytic leukaemia: mixed T-cell chimerism is associated with high relapse risk and inferior survivalPhilip A Thompson, Francesco Stingo, Michael J Keating, et al.
Pageof 12

Showing results (61-70 of 119) with videos related to

Sort By:
Pageof 12
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 18, 2018
Impact of Induction Therapy on the Outcome of Immunoglobulin Light Chain Amyloidosis after Autologous Hematopoietic Stem Cell TransplantationAimaz Afrough, Rima M Saliba, Amir Hamdi, et al.
Leukemia & Lymphoma|July 26, 2011
Feasibility of autologous hematopoietic stem cell transplant in patients aged ≥70 years with multiple myelomaQaiser Bashir, Nina Shah, Simrit Parmar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 25, 2015
General and Virus-Specific Immune Cell Reconstitution after Double Cord Blood TransplantationRima M Saliba, Katayoun Rezvani, Ann Leen, et al.
Bone Marrow Transplantation|November 18, 2018
Primary plasma cell leukemia: autologous stem cell transplant in an era of novel induction drugsLohith Gowda, Mithun Shah, Ifra Badar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 6, 2015
Outcome of Patients with Immunoglobulin Light-Chain Amyloidosis with Lung, Liver, Gastrointestinal, Neurologic, and Soft Tissue Involvement after Autologous Hematopoietic Stem Cell TransplantationAimaz Afrough, Rima M Saliba, Amir Hamdi, et al.
American Journal of Hematology|July 16, 2016
Outcomes in patients with multiple myeloma with TP53 deletion after autologous hematopoietic stem cell transplantSameh Gaballa, Rima M Saliba, Samer Srour, et al.
Blood|August 6, 2009
Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host diseaseSimrit Parmar, Marcos Del Lima, Yizhou Zou, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 17, 2017
Ex Vivo Mesenchymal Precursor Cell-Expanded Cord Blood Transplantation after Reduced-Intensity Conditioning Regimens Improves Time to Neutrophil RecoveryRohtesh S Mehta, Rima M Saliba, Kai Cao, et al.
The Lancet. Haematology|May 20, 2017
High-dose gemcitabine, busulfan, and melphalan for autologous stem-cell transplant in patients with relapsed or refractory myeloma: a phase 2 trial and matched-pair comparison with melphalanYago Nieto, Benigno C Valdez, Sai R Pingali, et al.
British Journal of Haematology|March 16, 2017
Long-term follow-up of patients receiving allogeneic stem cell transplant for chronic lymphocytic leukaemia: mixed T-cell chimerism is associated with high relapse risk and inferior survivalPhilip A Thompson, Francesco Stingo, Michael J Keating, et al.
Pageof 12